Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1916 1
1917 1
1918 1
1920 2
1922 1
1932 1
1935 1
1945 3
1946 10
1947 2
1948 5
1949 1
1950 4
1951 4
1952 5
1953 7
1954 6
1955 4
1956 5
1957 4
1958 4
1959 5
1960 8
1961 11
1962 8
1963 10
1964 11
1965 17
1966 7
1967 8
1968 13
1969 13
1970 19
1971 11
1972 8
1973 9
1974 9
1975 16
1976 15
1977 29
1978 23
1979 19
1980 22
1981 25
1982 23
1983 14
1984 27
1985 23
1986 30
1987 39
1988 26
1989 32
1990 32
1991 20
1992 36
1993 26
1994 27
1995 31
1996 34
1997 31
1998 26
1999 28
2000 29
2001 23
2002 41
2003 39
2004 38
2005 45
2006 40
2007 53
2008 63
2009 62
2010 80
2011 81
2012 85
2013 80
2014 90
2015 88
2016 89
2017 88
2018 107
2019 116
2020 112
2021 133
2022 104
2023 95
2024 65

Text availability

Article attribute

Article type

Publication date

Search Results

2,533 results

Results by year

Filters applied: . Clear all
Page 1
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice - Evidence-Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue.
Padmanabhan A, Connelly-Smith L, Aqui N, Balogun RA, Klingel R, Meyer E, Pham HP, Schneiderman J, Witt V, Wu Y, Zantek ND, Dunbar NM, Schwartz GEJ. Padmanabhan A, et al. Among authors: meyer e. J Clin Apher. 2019 Jun;34(3):171-354. doi: 10.1002/jca.21705. J Clin Apher. 2019. PMID: 31180581
CAR T cells with dual targeting of CD19 and CD22 in adult patients with recurrent or refractory B cell malignancies: a phase 1 trial.
Spiegel JY, Patel S, Muffly L, Hossain NM, Oak J, Baird JH, Frank MJ, Shiraz P, Sahaf B, Craig J, Iglesias M, Younes S, Natkunam Y, Ozawa MG, Yang E, Tamaresis J, Chinnasamy H, Ehlinger Z, Reynolds W, Lynn R, Rotiroti MC, Gkitsas N, Arai S, Johnston L, Lowsky R, Majzner RG, Meyer E, Negrin RS, Rezvani AR, Sidana S, Shizuru J, Weng WK, Mullins C, Jacob A, Kirsch I, Bazzano M, Zhou J, Mackay S, Bornheimer SJ, Schultz L, Ramakrishna S, Davis KL, Kong KA, Shah NN, Qin H, Fry T, Feldman S, Mackall CL, Miklos DB. Spiegel JY, et al. Among authors: meyer e. Nat Med. 2021 Aug;27(8):1419-1431. doi: 10.1038/s41591-021-01436-0. Epub 2021 Jul 26. Nat Med. 2021. PMID: 34312556 Free PMC article. Clinical Trial.
SLC39A14 Deficiency.
Tuschl K, Gregory A, Meyer E, Clayton PT, Hayflick SJ, Mills PB, Kurian MA. Tuschl K, et al. Among authors: meyer e. 2017 May 25 [updated 2022 Dec 8]. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Bean LJH, Gripp KW, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2024. 2017 May 25 [updated 2022 Dec 8]. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Bean LJH, Gripp KW, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2024. PMID: 28541650 Free Books & Documents. Review.
Nanotribology.
Gnecco E, Perkin S, Vanossi A, Meyer E. Gnecco E, et al. Among authors: meyer e. Beilstein J Nanotechnol. 2018 Aug 28;9:2330-2331. doi: 10.3762/bjnano.9.217. eCollection 2018. Beilstein J Nanotechnol. 2018. PMID: 30202701 Free PMC article. No abstract available.
The social informatics of knowledge.
Meyer ET, Shankar K, Willis M, Sharma S, Sawyer S. Meyer ET, et al. J Assoc Inf Sci Technol. 2019 Apr;70(4):307-312. doi: 10.1002/asi.24205. Epub 2019 Mar 5. J Assoc Inf Sci Technol. 2019. PMID: 31763357 Free PMC article.
Targeting ferroptosis protects against experimental (multi)organ dysfunction and death.
Van Coillie S, Van San E, Goetschalckx I, Wiernicki B, Mukhopadhyay B, Tonnus W, Choi SM, Roelandt R, Dumitrascu C, Lamberts L, Dams G, Weyts W, Huysentruyt J, Hassannia B, Ingold I, Lele S, Meyer E, Berg M, Seurinck R, Saeys Y, Vermeulen A, van Nuijs ALN, Conrad M, Linkermann A, Rajapurkar M, Vandenabeele P, Hoste E, Augustyns K, Vanden Berghe T. Van Coillie S, et al. Among authors: meyer e. Nat Commun. 2022 Feb 24;13(1):1046. doi: 10.1038/s41467-022-28718-6. Nat Commun. 2022. PMID: 35210435 Free PMC article.
Non-invasive tests for clinically significant portal hypertension after HCV cure.
Semmler G, Lens S, Meyer EL, Baiges A, Alvardo-Tapias E, Llop E, Tellez L, Schwabl P, Mauro E, Escudé L, Díez C, Ibañez-Samaniego L, Puente Á, Fortea JI, Abadía M, Zanetto A, Conthe A, Hernandez-Évole H, Luzko Scheid IS, Jia J, Yoshiji H, Francque SM, Tsochatzis EA, Russo FP, Crespo G, Forns X, Bañares R, Villanueva C, Hernández-Gea V, Reiberger T, Bosch J, García Pagán JC, Mandorfer M; A study by the Baveno Cooperation: an EASL consortium. Semmler G, et al. Among authors: meyer el. J Hepatol. 2022 Dec;77(6):1573-1585. doi: 10.1016/j.jhep.2022.08.025. Epub 2022 Sep 5. J Hepatol. 2022. PMID: 36063968 Free article.
Targeted knockout of a conserved plant mitochondrial gene by genome editing.
Forner J, Kleinschmidt D, Meyer EH, Gremmels J, Morbitzer R, Lahaye T, Schöttler MA, Bock R. Forner J, et al. Among authors: meyer eh. Nat Plants. 2023 Nov;9(11):1818-1831. doi: 10.1038/s41477-023-01538-2. Epub 2023 Oct 9. Nat Plants. 2023. PMID: 37814021 Free PMC article.
2,533 results